Showing results (231-240 of 391) with videos related to
Sort By:
Pageof 40
Radiology|September 3, 2024
Use of Pretreatment Perfusion MRI-based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant ChemoimmunotherapyToulsie Ramtohul, Victoire Lepagney, Claire Bonneau, et al.Oncogene|March 12, 2024
A novel bioinformatic approach reveals cooperation between Cancer/Testis genes in basal-like breast tumorsMarthe Laisné, Brianna Rodgers, Sarah Benlamara, et al.Clinical Epigenetics|July 3, 2025
Methylation-sensitive high-resolution melting technology is a simple and sensitive method to detect germline epimutation of the MLH1 gene promoterHélène Delhomelle, Olfa Trabelsi-Grati, Marie-Charlotte Villy, et al.Scientific Reports|April 26, 2020
The high protein expression of FOXO3, but not that of FOXO1, is associated with markers of good prognosisFrançois Lallemand, Sophie Vacher, Leanne de Koning, et al.Journal of Medical Genetics|October 21, 2022
APC germline pathogenic variants and epithelial ovarian cancer: causal or coincidental findings?Roseline Vibert, Jessica Le Gall, Bruno Buecher, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 18, 2024
E-Cadherin Mutational Landscape and Outcomes in Breast Invasive Lobular CarcinomaLounes Djerroudi, Amel Bendali, Laetitia Fuhrmann, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 21, 2023
Multicenter Harmonization Study of Pan-Trk Immunohistochemistry for the Detection of NTRK3 FusionsJulien Adam, Nolwenn Le Stang, Arnaud Uguen, et al.NPJ Breast Cancer|February 13, 2025
Clinico-pathological factors predicting pathological response in early triple-negative breast cancerClara Helal, Lounes Djerroudi, Toulsie Ramtohul, et al.Journal of Clinical Pathology|November 5, 2020
Neuroendocrine tumours of the breast: a genomic comparison with mucinous breast cancers and neuroendocrine tumours of other anatomic sitesFresia Pareja, Mahsa Vahdatinia, Caterina Marchio, et al.Plos One|May 24, 2013
TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancerVirginie Maire, Céline Baldeyron, Marion Richardson, et al.Pageof 40